GleamWall
中文EN

ITGR Integer Holdings Corp

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1114483 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.3%
TTM net income YoY19.3%
TTM EPS YoY22.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR8.0%

Margins

Gross margin24.6%
Operating margin8.2%
Net margin5.7%
FCF margin4.5%
EBITDA margin15.9%

Returns

ROE6.0%
ROA3.1%
ROIC (approx.)5.0%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets49.1%
Debt / equity0.71x
Current ratio3.98x
Interest coverage3.87x

Cash quality & payout

Operating cash flow / net income1.70x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-10-022026Q22026-07-032026Q12026-04-032025Q4*2025-12-312025Q32025-09-262025Q22025-06-272025Q12025-03-282024Q4*2024-12-31
Income statement
Revenue$449.66M$464.11M$439.58M$472.06M$467.69M$476.49M$437.39M$449.50M
Cost of revenue$348.10M$351.17M$329.99M$347.30M$341.53M$347.34M$317.07M$332.70M
Gross profit$101.56M$112.94M$109.59M$124.76M$126.16M$129.15M$120.32M$116.80M
R&D expense$13.53M$11.28M$16.24M$10.11M$10.95M$14.24M$14.20M$10.61M
SG&A expense$54.15M$57.70M$58.71M$57.21M$50.45M$52.92M$51.16M$47.47M
Operating income$28.21M$34.53M$31.87M$55.94M$56.44M$59.34M$49.55M$57.03M
Interest expense$9.70M$10.13M$9.73M$9.28M$9.37M$9.75M$14.80M$13.23M
Pretax income$17.51M$23.29M$20.35M$46.81M$45.99M$45.60M-$13.00M$39.26M
Income tax$2.53M-$314,000$3.85M-$1.80M$6.31M$8.59M$9.47M$6.29M
Net income$14.98M$23.61M$16.51M$48.61M$39.68M$37.01M-$22.49M$32.70M
EBITDA$62.56M$69.07M$66.88M$91.44M$89.48M$91.62M$79.38M$85.96M
EPS (basic)0.440.690.48—1.131.06-0.66—
EPS (diluted)0.430.690.48—1.111.04-0.66—
Weighted avg. shares (diluted)34.60M34.15M34.43M—35.61M35.71M33.92M—
Balance sheet
Cash & equivalents$14.13M$21.38M$8.12M$17.16M$58.94M$23.14M$31.71M$46.54M
Receivables$345.07M$338.73M$327.78M$346.08M$310.17M$302.26M$276.24M$245.27M
Inventory$278.59M$288.06M$284.48M$253.74M$263.54M$266.44M$260.10M$247.13M
Current assets$801.39M$810.63M$774.76M$770.10M$778.12M$737.43M$702.20M$671.12M
PP&E, net$535.13M$532.34M$533.14M$536.43M———$465.80M
Goodwill$1.10B$1.10B$1.11B$1.11B$1.10B$1.10B$1.08B$1.02B
Intangibles$770.09M$788.84M$806.34M$825.43M$837.70M$854.54M$856.21M$778.29M
Total assets$3.39B$3.42B$3.41B$3.41B$3.40B$3.37B$3.30B$3.08B
Current liabilities$201.12M$217.14M$206.34M$232.04M$209.82M$216.03M$206.40M$227.17M
Short-term debt$0$0$0$0$0$0$11,000$10.00M
Long-term debt$1.22B$1.24B$1.25B$1.19B$1.19B$1.20B$1.24B$980.15M
Total debt$1.22B$1.24B$1.25B$1.19B$1.19B$1.20B$1.24B$990.15M
Total liabilities$1.67B$1.70B$1.71B$1.66B$1.65B$1.67B$1.69B$1.46B
Shareholders' equity$1.73B$1.72B$1.70B$1.75B$1.75B$1.70B$1.61B$1.62B
Net debt$1.21B$1.22B$1.24B$1.17B$1.13B$1.18B$1.20B$943.61M
Shares outstanding34.00M33.99M33.95M34.35M35.04M35.03M34.89M33.55M
Cash flow statement
Operating cash flow$36.63M$59.73M$24.70M$55.41M$65.59M$43.86M$31.28M$63.23M
Capital expenditure$20.53M$22.69M$23.96M$27.48M$19.34M$19.00M$25.22M$19.09M
Free cash flow$16.10M$37.04M$737,000$27.94M$46.26M$24.86M$6.06M$44.14M
Investing cash flow-$20.51M-$22.68M-$37.90M-$35.47M-$20.27M-$17.83M-$197.17M$29.62M
Financing cash flow-$22.42M-$23.59M$3.83M-$61.72M-$10.71M-$35.59M$151.58M-$82.30M
Depreciation & amortization$34.35M$34.54M$35.01M$35.51M$33.04M$32.29M$29.83M$28.93M
Stock-based compensation$5.23M$5.38M$6.66M$5.76M$4.93M$5.66M$6.88M$6.04M
Share buybacks$0$0$50.00M$50.01M$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.